Holen Sie sich die Stockscreener-App
0.00
100.00%
-54.65
Akero Therapeutics Inc Aktie (AKRO) Neueste Nachrichten
Akero Therapeutics, Inc.(NasdaqGS:AKRO) dropped from S&P Biotechnology Select Industry Index - marketscreener.com
Akero Therapeutics' (AKRO) "Overweight" Rating Reiterated at Cantor Fitzgerald - MarketBeat
Novo Nordisk seals acquisition of Akero Therapeutics - medwatch.com
Stempoint Capital LP Reduces Stock Position in Akero Therapeutics, Inc. $AKRO - MarketBeat
Novo Nordisk concludes USD 4.7 billion acquisition of Akero Therapeutics - Medical Dialogues
Novo Nordisk A/S (CPSE: NOVO B) completed the acquisition of Akero Therapeutics, Inc.. - marketscreener.com
Novo Nordisk Concludes Up to $5.2 Billion Takeover of Akero Therapeutics - marketscreener.com
Akero Therapeutics completes merger with Novo Nordisk, delists from Nasdaq By Investing.com - Investing.com Canada
Akero Therapeutics Announces Merger and Delisting Plans - TipRanks
Akero Therapeutics completes merger with Novo Nordisk, delists from Nasdaq - Investing.com
Novo Nordisk buys Akero Therapeutics in $5.2B deal - breakingthenews.net
Novo Nordisk completes $4.7 billion acquisition of Akero Therapeutics - Investing.com
Vivo Capital LLC Buys 233,521 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Akero Therapeutics Announces Board and Executive Changes Following Merger - TradingView
Novo Nordisk completes $4.7 billion acquisition of Akero Therapeutics By Investing.com - Investing.com UK
Novo Nordisk completes acquisition of Akero Therapeutics - marketscreener.com
Novo Nordisk has completed its acquisition of Akero Therapeutics - GlobeNewswire
(AKRO) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Aug Mood: Why Akero Therapeutics Inc stock could benefit from AI revolution2025 Market WrapUp & Technical Pattern Based Buy Signals - BỘ NỘI VỤ
Akero Therapeutics, Inc. $AKRO Stock Holdings Lessened by Marshall Wace LLP - MarketBeat
JPMorgan Chase & Co. Sells 18,890 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Akero Therapeutics, Inc. $AKRO Position Boosted by Schroder Investment Management Group - MarketBeat
Akero Therapeutics, Inc. $AKRO Shares Sold by Russell Investments Group Ltd. - MarketBeat
Is Akero Therapeutics Inc. (0K4) stock a contrarian opportunity2025 Market Outlook & Low Risk Profit Maximizing Plans - Newser
Will Akero Therapeutics Inc. stock benefit from AI adoptionJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - Newser
What dividend safety rating applies to Akero Therapeutics Inc. (0K4) stockWeekly Market Outlook & Weekly Stock Performance Updates - Newser
Can Akero Therapeutics Inc. (0K4) stock deliver strong annual returnsWeekly Stock Analysis & Daily Price Action Insights - Newser
Novo Nordisk greenlighted by German antitrust authorities to acquire Akero - medwatch.com
Novo Nordisk wins German approval to buy Akero Therapeutics - MLex
Germany's cartel office says it approved acquisition of Akero Therapeutics by Novo Nordisk - marketscreener.com
Key facts: Novo Nordisk launches Ozempic in India; Dr Reddy's court nod; Akero acquisition approved - TradingView
Novo Nordisk-Akero Therapeutics deal gets green light in US - MLex
Akero Therapeutics shareholders approve acquisition by Novo Nordisk - Investing.com Nigeria
Akero Therapeutics stockholders approve acquisition by Novo Nordisk - marketscreener.com
Akero Therapeutics Shareholders Approve Novo Nordisk Merger - TipRanks
Prudential Financial Inc. Purchases 48,055 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Published on: 2025-12-02 04:35:40 - Newser
How Akero Therapeutics Inc. (0K4) stock moves on employment dataJuly 2025 Gainers & Free Reliable Trade Execution Plans - Newser
Loomis Sayles & Co. L P Acquires 51,850 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
SG Americas Securities LLC Sells 1,150,442 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
F m Investments LLC Has $960,000 Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Novo Nordisk to buy Akero Therapeutics for $5.2 billion over liver drug - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics - The National Law Review
Is Akero Therapeutics Inc a good long term investmentMoving Average Strategies & Free High Profit Capital Plays - earlytimes.in
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
7,107 Shares in Akero Therapeutics, Inc. $AKRO Bought by DLD Asset Management LP - MarketBeat
Rhenman & Partners Asset Management AB Acquires 105,100 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
5,700 Shares in Akero Therapeutics, Inc. $AKRO Bought by North Star Asset Management Inc. - MarketBeat
Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc.AKRO - Business Wire
(AKRO) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Foresite Capital Management VI LLC Has $13.07 Million Stock Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Creative Planning Purchases 25,643 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Ensign Peak Advisors Inc Has $10.05 Million Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
What drives Akero Therapeutics Inc 0K4 stock priceAnalyst Upgrades & Fast Growing Stocks - earlytimes.in
Akero Therapeutics, Inc. $AKRO Shares Sold by Geode Capital Management LLC - MarketBeat
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):